万赛维价格多少？

(Valganciclovir Hydrochloride) is an oral anti-cytomegalovirus infection drug developed by the Swiss company Roche. Its main ingredient is valganciclovir hydrochloride. Currently approved indications include induction treatment of CMV retinitis, maintenance treatment of CMV retinitis and prevention of CMV infection in transplant patients.

How much does Vansevir (valganciclovir hydrochloride) cost?

It is reported that Vancevir (valganciclovir hydrochloride) has been launched in China, and the price is relatively expensive. Most patients say they cannot afford it. The domestic Vancevir (valganciclovir hydrochloride) specification is 450mg-60 tablets/box, and the price is about US$2,250.

Fortunately, Roche's Valganciclovir (valganciclovir hydrochloride) is also on the market in India, and its price is the lowest in the world. India's Valganciclovir (valganciclovir hydrochloride) is 450mg*60 tablets/box, priced at about US$750. Due to the floating exchange rate, the price is not fixed. Please consult Medical Travel for specific prices.

The Indian version of Vancevir (Valganciclovir Hydrochloride) is currently not available for sale in China. Hospitals or pharmacies cannot buy the Indian version of Vancevir (Valganciclovir Hydrochloride). If patients need it, they can go to Indian pharmacies to buy the medicine in person or ask relatives or friends to bring it back. If the above two methods are not feasible, You can also purchase authentic Indian Valganciclovir Hydrochloride Tablets through formal and reliable channels, that is, choose a professional overseas medical service organization trusted by many patients [such as Medical Companion Travel]. Through this organization, you can directly purchase Indian Valganciclovir Hydrochloride Tablets without leaving home. The drug safety is guaranteed and the cost is transparent. If you need help, please consult the medical companion passenger service.

Induction therapy of CMV retinitis: For patients with active CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) twice daily for 21 days. Prolonged induction therapy may increase the risk of bone marrow toxicity. Maintenance treatment of CMV retinitis: After induction therapy, or in patients with inactive CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) once daily. Induction therapy may be repeated in patients with worsening retinitis. Prevention of CMV infection in transplant patients: For patients who have received solid organ transplants, the recommended dose of valganciclovir hydrochloride is 900 mg (two 450 mg tablets) once daily, starting within 10 days after transplantation and continuing until 100 days after transplantation.